NCT00115388

Brief Summary

Chlamydial infection is a common, sexually transmitted disease which women can have without knowing. Untreated, it can lead to an infection of the womb and fallopian tubes called pelvic inflammatory disease (PID), which can cause infertility. There has been only one trial of chlamydia screening and this was in American women in 1992 and used outdated tests. We now need to see if screening using modern tests and self-taken swabs works in a high risk, young, multiethnic female population in the United Kingdom (UK). The study is a randomised trial. It will involve asking women students in college bars to complete confidential questionnaires on sexual health and to provide self-administered vaginal swabs. We have successfully done this in a small pilot study. Participants will be told that the tests are for research purposes only and that if they think they may have been at risk of a sexually transmitted infection they should get checked at a clinic. If the trial shows that chlamydia screening using these new methods prevents PID, extending this community-based intervention nationwide could improve women's reproductive health and wellbeing and might prevent some women from becoming infertile

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,531

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Sep 2004

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2004

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

June 21, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 22, 2005

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
Last Updated

November 24, 2014

Status Verified

November 1, 2014

Enrollment Period

4.3 years

First QC Date

June 21, 2005

Last Update Submit

November 21, 2014

Conditions

Keywords

Pelvic inflammatory diseaseChlamydia trachomatisScreening

Outcome Measures

Primary Outcomes (1)

  • Primary outcome measure in the complete cohort: Incidence of clinical PID over 12 months in intervention and control groups.

    12 months

Secondary Outcomes (6)

  • Secondary outcome measures after 12 months in women with chlamydial infection at baseline:

    12 months

  • Control group (untreated):

    12 months

  • Incidence of PID.

    12 months

  • Percentage with spontaneous clearance of genital infection.

    12 months

  • Relative risk of PID in women with and without BV

    12 months

  • +1 more secondary outcomes

Study Arms (1)

Deferred screening control group

OTHER

Samples from women in the control group were stored and tested at the end of the trial

Procedure: Screening for chlamydia using self-taken vaginal swabs

Interventions

Women in the intervention group will be tested for chlamydia and those found to be infected will be referred for treatment and partner notification

Deferred screening control group

Eligibility Criteria

Age16 Years - 27 Years
Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Sexually active

You may not qualify if:

  • Never been sexually active
  • Tested for chlamydia in past 3 months and no new sexual partner since then
  • Pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St George's Hospital Medical School

London, Sw17 ORE, United Kingdom

Location

Related Publications (4)

  • Hay PE, Kerry SR, Normansell R, Horner PJ, Reid F, Kerry SM, Prime K, Williams E, Simms I, Aghaizu A, Jensen J, Oakeshott P. Which sexually active young female students are most at risk of pelvic inflammatory disease? A prospective study. Sex Transm Infect. 2016 Feb;92(1):63-6. doi: 10.1136/sextrans-2015-052063. Epub 2015 Jun 16.

  • Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, Simms I, Hay P. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ. 2010 Apr 8;340:c1642. doi: 10.1136/bmj.c1642.

  • Oakeshott P, Kerry S, Atherton H, Aghaizu A, Hay S, Taylor-Robinson D, Simms I, Hay P. Community-based trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. Trials. 2008 Dec 10;9:73. doi: 10.1186/1745-6215-9-73.

  • Atherton H, Banks D, Harbit R, Long L, Chadd F, Hay P, Kerry S, Simms I, Oakeshott P. Recruitment of young women to a trial of chlamydia screening - as easy as it sounds? Trials. 2007 Dec 4;8:41. doi: 10.1186/1745-6215-8-41.

MeSH Terms

Conditions

Pelvic Inflammatory DiseaseChlamydia Infections

Interventions

Mass Screening

Condition Hierarchy (Ancestors)

Pelvic InfectionInfectionsAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesChlamydiaceae InfectionsGram-Negative Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesSexually Transmitted Diseases, BacterialSexually Transmitted DiseasesCommunicable Diseases

Intervention Hierarchy (Ancestors)

Diagnostic Techniques and ProceduresDiagnosisHealth SurveysSurveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesDiagnostic ServicesPreventive Health ServicesHealth ServicesHealth Care Facilities Workforce and ServicesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public HealthPublic Health Practice

Study Officials

  • Pippa Oakeshott, MD FRCP

    St George's, University of London

    PRINCIPAL INVESTIGATOR
  • Phillip Hay, FRCP

    St George's, University of London

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of General Practice

Study Record Dates

First Submitted

June 21, 2005

First Posted

June 22, 2005

Study Start

September 1, 2004

Primary Completion

December 1, 2008

Study Completion

December 1, 2008

Last Updated

November 24, 2014

Record last verified: 2014-11

Locations